Meta-analysis of GAMD, NVAMD, and PS (caused by AMD) prevalence, aged 65–79 years
| Condition | Sex | Number of studies used | Test for heterogeneity between studies (p value) | Effects model used for combined estimate | Combined percentage prevalence for age groups 65–79 years (95% CI) |
|---|---|---|---|---|---|
| PS = partial sighted, best VA 6/18 to >6/60, caused by AMD, GAMD = geographical/dry/atrophic/non-exudative/late AMD in at least one eye, NVAMD = neovascular/exudative/wet AMD in at least one eye. | |||||
| GAMD | Male | 5 | 0.702 | Fixed | 0.60 (0.35 to 0.85) |
| Female | 5 | 0.542 | Fixed | 0.45 (0.26 to 0.64) | |
| All | 5 | 0.367 | Fixed | 0.53 (0.37 to 0.68) | |
| NVAMD | Male | 5 | 0.239 | Fixed | 0.81 (0.52 to 1.11) |
| Female | 5 | 0.011 | Random | 1.03 (0.49 to 1.58) | |
| All | 5 | 0.001 | Random | 1.05 (0.57 to 1.52) | |
| AMD related PS | Male | 6 | 0.173 | Fixed | 0.15 (0.03 to 0.27) |
| Female | 6 | 0.050 | Fixed | 0.21 (0.09 to 0.33) | |
| All | 6 | 0.003 | Random | 0.35 (0.14 to 0.57) | |